To further investigate the role of GPX4 and connexin43 in NBO‐induced protection, rats were pretreated with a connexin43 inhibitor (Gap27) or GPX4 activator (Ferrostatin‐1) to regulate the GPX4 pathway. Here, GPX4 is linked to chronic recurrent multifocal osteomyelitis.